{"entity":{"id":"birgitte-klindt-poulsen","kind":"person","name":"Birgitte Klindt Poulsen","aka":[],"tldr":"Birgitte Klindt Poulsen chairs Medicinrådet, the council that decides which new hospital medicines Denmark's regions take into standard use.","summary":"Birgitte Klindt Poulsen is named as forperson (chair) of Medicinrådet in its 2026 announcements. Commenting on the recommendation of the CAR-T therapy brexucabtagene autoleucel under an outcome-based risk-sharing agreement, she said that the treatment is very expensive and its effect uncertain, and that the agreement lets the health service use it and collect data on its effect in Danish practice; on trastuzumab deruxtecan she said the council would like to see more such agreements.","asOf":"2026-11-11","links":[{"label":"Medicinrådet: ny effektbaseret aftale baner vejen for behandling til kræftpatienter","url":"https://medicinraadet.dk/nyheder/2026/ny-effektbaseret-aftale-baner-vejen-for-behandling-til-kraeftpatienter"},{"label":"Medicinrådet: ny risikodelingsaftale åbner for behandling af to typer kræft","url":"https://medicinraadet.dk/nyheder/2026/ny-risikodelingsaftale-abner-for-behandling-af-to-typer-kraeft"}],"tags":["government"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":["brexucabtagene-autoleucel","trastuzumab-deruxtecan"],"companies":[],"institutions":["medicinraadet"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Chair (forperson), Medicinrådet (Danish Medicines Council)","institutionId":"medicinraadet","specialisms":["Medicines prioritisation","Health technology assessment"],"profiles":[{"label":"Medicinrådet: risk-sharing agreement for brexucabtagene autoleucel (2026)","url":"https://medicinraadet.dk/nyheder/2026/ny-effektbaseret-aftale-baner-vejen-for-behandling-til-kraeftpatienter"}],"papers":[]},"route":"/people/birgitte-klindt-poulsen/","neighbours":{"drug":[{"id":"brexucabtagene-autoleucel","kind":"drug","name":"Brexucabtagene autoleucel","route":"/drugs/brexucabtagene-autoleucel/"},{"id":"trastuzumab-deruxtecan","kind":"drug","name":"Trastuzumab deruxtecan","route":"/drugs/trastuzumab-deruxtecan/"}],"institution":[{"id":"medicinraadet","kind":"institution","name":"Medicinrådet (Danish Medicines Council)","route":"/institutions/medicinraadet/"}]}}